Hospital Acquired Infection Control Market by Product & Service [Sterilization (Equipment, Services), Disinfectants (Hand, Skin, Surface, Wipes, Sprays)], End User (Hospitals, Nursing Homes, Diagnostic Centers)- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2021-2027

The global Hospital Acquired Infection Control market gathered revenue around USD 28.9 Billion in 2020 and market is set to grow USD 34.2 Billion by the end of 2027 and is estimated to expand at a modest CAGR of 3.0% during the prediction period 2021 to 2027.

Growth Factors:

The growth of the hospital acquired infection control market can largely be attributed to factors such as the high incidence of hospital-acquired infections, the increasing number of surgical procedures, the growing geriatric population and the increasing incidence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental & personal hygiene due to COVID-19.

The increasing use of E-beam sterilization, reintroduction of ethylene oxide sterilization, and the growing healthcare industry and outsourcing of operation to emerging countries are expected to offer high-growth opportunities for market players during the forecast period.

Currently, with the surge in COVID-19 cases, there is an increasing focus on personal hygiene along with the increasing production of medical nonwovens and single-use products such as face masks and gloves. This is further expected to drive the growth of the hospital acquired infection control market in the coming years.

This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Hospital Acquired Infection Control market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Hospital Acquired Infection Control market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.

Report Coverage

COVID-19 Impact Assessment on Market Landscape

The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.

Hospital Acquired Infection Control market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.

Regional analysis:

North America dominated the market and accounted for the largest revenue share of more than 35.0% in 2020.  The large share can be attributed to the presence of key players, initiatives implemented by them in the public and private sector, and increasing awareness of HAIs in this region.FO instance, in December 2020, Ecolab, headquartered in the U.S. acquired vanBaerle Hygiene AG in Switzerland. This added a full range of cleaning, disinfectant, and hygiene solutions to Ecolab’s product line and service capabilities.

In the U.S., the CDC is responsible for outbreak investigations, surveillance, research, and prevention of HAIs. The CDC also devises new strategies to prevent healthcare-associated infections in accordance with the HHS Action Plan to Prevent Healthcare-Associated in acute care hospitals. Such supportive initiatives are expected to drive regional growth in the coming years.

In Asia Pacific, the market is estimated to witness the fastest CAGR of 5.7% over the next few years. This is owing to the rising prevalence of hospital acquired infections and developing healthcare infrastructure in low and middle-income economies. According to the World Health Organization (WHO), the frequency of ICU-acquired infection is 2 to 3 times higher in low- and middle-income countries compared to high-income countries. Whereas device-associated infections are about 13 times higher than in the U.S. In addition, newborns in developing countries are at a higher risk of contracting healthcare-associated infections than in high-income countries. The WHO pegs the infection rates at about 3 to 20 times higher. This is expected to fuel the market growth, especially in the Latin American, MEA, and Asia Pacific regions.

Competitive Rivalry

Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

• Company Overview
• Company Market Share/Positioning Analysis
• Product Offerings
• Financial Performance
• Recent Initiatives
• Key Strategies Adopted by Players
• Vendor Landscape
• List of Suppliers
• List of Buyers

Some of the prominent players in the Hospital Acquired Infection Control Market include: Olympus Corporation; BD; Getinge AB; Xenex Disinfection Services Inc.; 3M; STERIS; ASP (Advanced Sterilization Products); Ecolab; Belimed AG; KCWW (Kimberly-Clark Worldwide, Inc.)

Unravelling the Critical Segments

This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:

Global hospital acquired infection control market, by Product & Services

• Protective Barrier
• Sterilization
• Disinfectants
• Disinfectant, By Product
• Hand Disinfectants
• Surface Disinfectants
• Skin Disinfectants
• Instrument Disinfectants
• Disinfectant, By Formulation
• Liquid Disinfectants
• Disinfectant Wipes
• Disinfectant Sprays
• Disinfectors
• Endoscope Reprocessing Products
• Other Infection Control Products  

Global hospital acquired infection control market, by End User

• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers

By Geography

North America

• U.S.
• Canada

Europe

• Germany
• France
• United Kingdom
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Southeast Asia
• Rest of Asia Pacific

Latin America

• Brazil
• Rest of Latin America

Middle East & Africa (MEA)

• GCC
• North Africa
• South Africa
• Rest of Middle East & Africa

Highlights of the Report:

• Market Penetration: Comprehensive information on the product portfolios of the top players in the market.
• Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market
• Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market
• Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the market

Research Methodology

In the study, a unique research methodology is utilized to conduct extensive research on the growth of the Hospital Acquired Infection Control market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the Hospital Acquired Infection Control market study are as follows - statistics from government organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, all of whom have contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the market, and makes the projections on the growth prospects of the Hospital Acquired Infection Control markets more accurate and reliable.

Secondary Research

It involves company databases such as Hoover's: This assists us recognize financial information, structure of the market participants and industry competitive landscape.

The secondary research sources referred in the process are as follows:

• Governmental bodies, and organizations creating economic policies
• National and international social welfare institutions
• Company websites, financial reports and SEC filings, broker and investor reports
• Related patent and regulatory databases
• Statistical databases and market reports
• Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to face interviews, online surveys, and telephonic interviews.

• Means of primary research: Email interactions, telephonic discussions and Questionnaire based research etc.
• In order to validate our research findings and analysis we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

Industry participants involved in this research study include:

• CEOs, VPs, market intelligence managers
• Procuring and national sales managers technical personnel, distributors and resellers
• Research analysts and key opinion leaders from various domains

Key Points Covered in Hospital Acquired Infection Control market Study:

• Growth of Hospital Acquired Infection Control in 2021
• Market Estimates and Forecasts (2017-2027)
•  Brand Share and Market Share Analysis
•  Key Drivers and Restraints Shaping Market Growth
•  Segment-wise, Country-wise, and Region-wise Analysis
•  Competition Mapping and Benchmarking
•  Recommendation on Key Winning Strategies
•  COVID-19 Impact on Demand for Hospital Acquired Infection Control and How to Navigate
•  Key Product Innovations and Regulatory Climate
•  Hospital Acquired Infection Control Consumption Analysis
•  Hospital Acquired Infection Control Production Analysis
•  Hospital Acquired Infection Control and Management